Summit Therapeutics Inc. (SMMT) quarterly income statement — complete revenue, gross profit & net income history
Summit Therapeutics Inc. (SMMT) annual income statement — 23-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.01K | 193.05K | 190.31K | 185.61K |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -79.72% | 368.5% | 36.64% | 37.2% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.01K | 193.05K | 190.31K | 185.61K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -79.72% | 368.5% | 36.64% | 37.2% |
| Operating Expenses | 214.61M | 220.5M | 195.21M | 224.88M | 234.21M | 414.14M | 51.75M | 52.41M | 43.66M | 47.16M | 33.59M | 28.4M | 16.8M | 12.44M | 435.41M | 16.79M | 15.37M | 10.62M | 17.06M | 19.45M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7800.03% | 5500.87% | 8963.2% | 10477.35% |
| Selling, General & Admin | 45.48M | 62.76M | 62.59M | 77.58M | 103.11M | 262.58M | 12.06M | 11.53M | 15.25M | 10.93M | 9.13M | 9.08M | 4.45M | 4.97M | 5.63M | 6.27M | 4.99M | 5.7M | 5.07M | 5.75M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2533.19% | 2950.23% | 2663.6% | 3099.62% |
| Research & Development | 169.13M | 157.73M | 132.62M | 147.29M | 131.1M | 151.56M | 39.68M | 41.04M | 28.22M | 36.23M | 24.47M | 19.46M | 12.56M | 7.44M | 430.26M | 4.46M | 15.27M | 7.4M | 15.65M | 17.09M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7749.58% | 3833.21% | 8222.4% | 9206.02% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -163.74K | 197.46K | 0 | 0 | -140.41K | -217.21K | 21.26K | -473.5K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -214.61M | -220.5M | -195.21M | -224.88M | -234.21M | -414.14M | -51.75M | -52.41M | -43.66M | -47.16M | -33.59M | -28.4M | -16.8M | -12.44M | -435.41M | -16.79M | -15.17M | -10.43M | -16.87M | -19.26M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7700.03% | -5400.87% | -8863.2% | -10377.34% |
| Operating Income Growth % | 8.37% | 46.76% | -277.24% | -329.08% | -436.4% | -778.13% | -54.05% | -84.51% | -159.96% | -279.21% | 92.28% | -69.16% | -10.72% | -19.28% | -2481.28% | 12.82% | -4.9% | 39.22% | -37.4% | -127.93% |
| EBITDA | -214.53M | -220.45M | -195.17M | -224.83M | -234.17M | -414.1M | -51.72M | -52.39M | -43.64M | -47.14M | -33.57M | -28.38M | -16.77M | -12.4M | -435.34M | -16.54M | -14.89M | -10.15M | -16.63M | -19.02M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7559.12% | -5260.02% | -8736.4% | -10246.67% |
| EBITDA Growth % | 8.39% | 46.76% | -277.34% | -329.18% | -436.55% | -778.43% | -54.07% | -84.59% | -160.25% | -280.16% | 92.29% | -71.59% | -12.61% | -22.12% | -2518.31% | 13.03% | -4.8% | 39.93% | -38.17% | -134.35% |
| D&A (Non-Cash Add-back) | 85K | 46K | 44K | 42K | 42K | 37K | 25K | 22K | 20K | 20K | 21.4K | 23.53K | 26.23K | 36.22K | 72.95K | 252.3K | 277.6K | 271.92K | 241.32K | 242.55K |
| EBIT | -208.38M | -215.7M | -189.42M | -219.12M | -231.79M | -414.14M | -48.7M | -48.88M | -39.62M | -35.29M | -31.33M | -25.79M | -14.71M | -9.07M | -13.16M | -10.83M | -18.46M | -13.12M | -16.14M | -18.99M |
| Net Interest Income | 6.5M | 4.39M | 5.85M | 5.88M | 2.78M | 2.98M | 0 | 13.46M | -2.46M | -3.1M | -3.12M | -522K | -237K | 771K | -8.33M | -2.9M | -692K | -653K | -152K | -1.05M |
| Interest Income | 6.5M | 4.39M | 5.85M | 5.88M | 2.78M | 2.98M | 0 | 13.47M | 0 | 0 | 0 | 2.38M | 2.48M | 3.29M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 2.46M | 3.1M | 3.12M | 2.9M | 2.72M | 2.52M | 8.33M | 2.9M | 692K | 653K | 152K | 1.05M |
| Other Income/Expense | 6.23M | 4.8M | 5.79M | 5.75M | 2.42M | 1.99M | 3.05M | 3.52M | 1.59M | -607.54K | -859.04K | -280.04K | -636.06K | 848.06K | -4.23M | 885.13K | -3.98M | -3.35M | 579.32K | -777.92K |
| Pretax Income | -208.38M | -215.7M | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9720.49% | -7136.63% | -8558.8% | -10796.47% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -208.38M | -215.7M | -189.42M | -219.17M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9720.49% | -7136.63% | -8558.8% | -10796.47% |
| Net Income Growth % | 10.1% | 47.66% | -288.97% | -348.34% | -450.9% | -762.81% | -41.36% | -70.43% | -141.36% | -312.2% | 92.16% | -80.33% | 8.97% | 15.89% | -2599.08% | 20.62% | -31.67% | 21.94% | -28.4% | -102.38% |
| Net Income (Continuing) | -208.38M | -215.7M | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.26 | -0.28 | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -1.16 | -0.06 | -0.13 | -0.14 | -0.17 | -0.21 |
| EPS Growth % | 16.13% | 50% | -244.33% | -305.03% | -418.39% | -686.52% | -41.96% | -75.06% | -139.2% | -328.92% | 95.77% | 31.14% | 80.77% | 88.14% | -582.35% | 71.71% | 13.33% | 30% | -13.33% | -61.54% |
| EPS (Basic) | -0.26 | -0.28 | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -1.16 | -0.06 | -0.13 | -0.14 | -0.17 | -0.21 |
| Diluted Shares Outstanding | 798.2M | 778.18M | 775.46M | 766.4M | 743.42M | 742.62M | 738.08M | 737.5M | 726.66M | 707.9M | 701.78M | 700.6M | 697.74M | 697.68M | 378.16M | 274.7M | 148.58M | 99.65M | 98.07M | 96.78M |
| Basic Shares Outstanding | 798.2M | 778.18M | 775.46M | 766.4M | 743.42M | 742.61M | 699.04M | 683.17M | 703.17M | 670.94M | 701.79M | 700.61M | 697.75M | 697.69M | 378.16M | 267.93M | 148.58M | 99.65M | 98.07M | 96.72M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |